Employees Retirement System of Texas’s Viking Therapeutics VKTX Stock Holding History

Employees Retirement System of Texas’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-138,826	Closed	-$416K	–	777
2022 Q1	$416K	Hold	138,826	–	–	0.01%	713
2021 Q4	$639K	Hold	138,826	–	–	0.01%	698
2021 Q3	$872K	Hold	138,826	–	–	0.01%	707
2021 Q2	$832K	Hold	138,826	–	–	0.01%	679
2021 Q1	$878K	Hold	138,826	–	–	0.01%	680
2020 Q4	$782K	Hold	138,826	–	–	0.01%	597
2020 Q3	$808K	Hold	138,826	–	–	0.01%	653
2020 Q2	$1M	Hold	138,826	–	–	0.02%	639
2020 Q1	$650K	Hold	138,826	–	–	0.01%	658
2019 Q4	$1.11M	Hold	138,826	–	–	0.02%	678
2019 Q3	$955K	Buy	138,826 +54,826	+65%	+$407K	0.02%	717
2019 Q2	$697K	Hold	84,000	–	–	0.01%	899
2019 Q1	$835K	Hold	84,000	–	–	0.01%	854
2018 Q4	$643K	Buy	84,000 +31,000	+58%	+$371K	0.01%	904
2018 Q3	$923K	Sell	53,000 -9,000	-15%	-$107K	0.01%	871
2018 Q2	$588K	Hold	62,000	–	–	0.01%	982
2018 Q1	$271K	Buy	+62,000	New	+$343K	﹤0.01%	1013

Other funds holding VKTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Employees Retirement System of Texas's VKTX Position: Q2 2022 in Review

Employees Retirement System of Texas sold out of Viking Therapeutics (VKTX) in Q2 2022, closing a stake of 138,826 shares — an estimated $416K sold.

Employees Retirement System of Texas first reported a position in VKTX in Q1 2018 and held it in 17 quarters. The position peaked at $1.11M in Q4 2019. 114 funds tracked by Wall St. Rank hold VKTX as of Q2 2022.

Employees Retirement System of Texas reported no remaining Viking Therapeutics position as of Q2 2022 after selling out during the quarter.
Employees Retirement System of Texas sold 138,826 Viking Therapeutics shares in Q2 2022, an estimated $416K.
Employees Retirement System of Texas first reported a position in Viking Therapeutics in Q1 2018 and held it in 17 quarters.
Employees Retirement System of Texas's Viking Therapeutics position peaked at $1.11M in Q4 2019.
114 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2022.

Based on Employees Retirement System of Texas's 13F filing for Q2 2022, filed 8 Aug 2022.